John D Bisognano

Summary

Affiliation: University of Rochester
Country: USA

Publications

  1. doi request reprint Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled rheos pivotal trial
    John D Bisognano
    Department of Medicine, Cardiology Division, University of Rochester Medical Center, Rochester, New York, USA
    J Am Coll Cardiol 58:765-73. 2011
  2. doi request reprint Creating community collaboration to improve the care of patients with high blood pressure: lessons from Rochester, New York
    John D Bisognano
    Cardiology Division, University of Rochester Medical Center, 601 Elmwood Ave, Rochester, NY 14642, USA
    J Clin Hypertens (Greenwich) 14:178-83. 2012
  3. pmc Calcium channel blockers, angiotensin receptor blockers, and angiotensin-converting enzyme inhibitors: effectiveness in combination with diuretics or beta-blockers for treating hypertension
    John D Bisognano
    Department of Internal Medicine, Cardiology Division, University of Rochester Medical Center, New York 14642 8679, USA
    Vasc Health Risk Manag 3:579-85. 2007
  4. ncbi request reprint Prevalence of comorbidities and their influence on blood pressure goal attainment in geriatric patients
    John D Bisognano
    Program in Heart Failure and Transplantation, Cardiac Rehabilitation, and Clinical Preventive Cardiology, University of Rochester, Rochester, NY 14642 8679, USA
    Am J Geriatr Cardiol 16:24-9. 2007
  5. pmc Cost-effectiveness of treating resistant hypertension with an implantable carotid body stimulator
    Kate C Young
    Department of Surgery, School of Medicine and Dentistry, University of Rochester, Rochester, NY 14620, USA
    J Clin Hypertens (Greenwich) 11:555-63. 2009
  6. ncbi request reprint Improving care in resistant hypertension: medication trends and nonpharmacologic strategies in a specialty clinic
    Michael W Fong
    Department of Medicine, Cardiology Division, University of Rochester Medical Center, Rochester, New York, USA
    Am J Cardiovasc Drugs 7:449-52. 2007
  7. doi request reprint Baroreflex activation therapy provides durable benefit in patients with resistant hypertension: results of long-term follow-up in the Rheos Pivotal Trial
    George L Bakris
    Department of Medicine, Hypertensive Diseases Unit, University of Chicago Pritzker Medical School, Chicago, IL, USA
    J Am Soc Hypertens 6:152-8. 2012
  8. doi request reprint Baroreflex stimulation in antihypertensive treatment
    Jeremy G Taylor
    Department of Internal Medicine, Nephrology Division, University of Rochester, 601 Elmwood Avenue, Box 679 7, Rochester, NY 14642 8679, USA
    Curr Hypertens Rep 12:176-81. 2010
  9. doi request reprint Renin inhibition for hypertension: selecting the right role for a new class of drug
    Jon Bergset
    Department of Internal Medicine, Cardiology Division, University of Rochester Medical Center, Rochester, NY 14642, USA
    Am J Ther 17:182-7. 2010
  10. doi request reprint Implantable device therapy for the treatment of resistant hypertension
    Nikhil Joshi
    Department of Internal Medicine, University of Rochester Medical Center, Rochester, NY, USA
    J Cardiovasc Transl Res 2:150-3. 2009

Collaborators

Detail Information

Publications35

  1. doi request reprint Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled rheos pivotal trial
    John D Bisognano
    Department of Medicine, Cardiology Division, University of Rochester Medical Center, Rochester, New York, USA
    J Am Coll Cardiol 58:765-73. 2011
    ..We sought to determine the effect of baroreflex activation therapy (BAT) on systolic blood pressure (SBP) in patients with resistant hypertension...
  2. doi request reprint Creating community collaboration to improve the care of patients with high blood pressure: lessons from Rochester, New York
    John D Bisognano
    Cardiology Division, University of Rochester Medical Center, 601 Elmwood Ave, Rochester, NY 14642, USA
    J Clin Hypertens (Greenwich) 14:178-83. 2012
    ..This report describes the process to date and hopefully will stimulate conversations about mechanisms to encourage similar collaboration within other communities...
  3. pmc Calcium channel blockers, angiotensin receptor blockers, and angiotensin-converting enzyme inhibitors: effectiveness in combination with diuretics or beta-blockers for treating hypertension
    John D Bisognano
    Department of Internal Medicine, Cardiology Division, University of Rochester Medical Center, New York 14642 8679, USA
    Vasc Health Risk Manag 3:579-85. 2007
    ..3%, 40.0%, and 32.2%, respectively. DHPs, ACE inhibitors, and ARBs improved BP when added to patients' beta-blocker or diuretic therapy. The greatest benefits were observed with DHPs, followed by ACE inhibitors, then ARBs...
  4. ncbi request reprint Prevalence of comorbidities and their influence on blood pressure goal attainment in geriatric patients
    John D Bisognano
    Program in Heart Failure and Transplantation, Cardiac Rehabilitation, and Clinical Preventive Cardiology, University of Rochester, Rochester, NY 14642 8679, USA
    Am J Geriatr Cardiol 16:24-9. 2007
    ..A diagnosis of heart failure was associated with lower odds of not achieving blood pressure goal. These issues should be given special consideration during the evaluation, treatment selection, and long-term monitoring of this population...
  5. pmc Cost-effectiveness of treating resistant hypertension with an implantable carotid body stimulator
    Kate C Young
    Department of Surgery, School of Medicine and Dentistry, University of Rochester, Rochester, NY 14620, USA
    J Clin Hypertens (Greenwich) 11:555-63. 2009
    ..Rheos may be cost-effective, with an ICER between $50,000 and $100,000 per QALYs. Cohort characteristics and efficacy are key to the cost-effectiveness of new therapies for resistant hypertension ...
  6. ncbi request reprint Improving care in resistant hypertension: medication trends and nonpharmacologic strategies in a specialty clinic
    Michael W Fong
    Department of Medicine, Cardiology Division, University of Rochester Medical Center, Rochester, New York, USA
    Am J Cardiovasc Drugs 7:449-52. 2007
    ..Resistant hypertension is an important clinical problem that is poorly studied and not well managed. The objective of this study was to identify factors associated with successful treatment of resistant hypertension in a specialty clinic...
  7. doi request reprint Baroreflex activation therapy provides durable benefit in patients with resistant hypertension: results of long-term follow-up in the Rheos Pivotal Trial
    George L Bakris
    Department of Medicine, Hypertensive Diseases Unit, University of Chicago Pritzker Medical School, Chicago, IL, USA
    J Am Soc Hypertens 6:152-8. 2012
    ..BAT substantially reduced arterial pressure for most patients participating in the Rheos Pivotal Trial. This blood pressure reduction or goal achievement was maintained over long-term follow-up of 22 to 53 months...
  8. doi request reprint Baroreflex stimulation in antihypertensive treatment
    Jeremy G Taylor
    Department of Internal Medicine, Nephrology Division, University of Rochester, 601 Elmwood Avenue, Box 679 7, Rochester, NY 14642 8679, USA
    Curr Hypertens Rep 12:176-81. 2010
    ..The early study results using baroreflex stimulation therapy are promising and suggest that it may play a significant role in controlling blood pressure in the future...
  9. doi request reprint Renin inhibition for hypertension: selecting the right role for a new class of drug
    Jon Bergset
    Department of Internal Medicine, Cardiology Division, University of Rochester Medical Center, Rochester, NY 14642, USA
    Am J Ther 17:182-7. 2010
    ..This article explores the role of aliskiren in treating hypertension as well as its side effects and appropriate dosing...
  10. doi request reprint Implantable device therapy for the treatment of resistant hypertension
    Nikhil Joshi
    Department of Internal Medicine, University of Rochester Medical Center, Rochester, NY, USA
    J Cardiovasc Transl Res 2:150-3. 2009
    ..This review discusses the evolution of this therapy including a review of the current data available from the early stages of ongoing clinical trials...
  11. ncbi request reprint Improved control of resistant hypertension with device-mediated electrical carotid sinus baroreflex stimulation
    James A Sloand
    Division of Medicine, Department of Nephrology, University of Rochester, Rochester, NY 14620, USA
    J Clin Hypertens (Greenwich) 9:716-9. 2007
  12. ncbi request reprint Baroreflex stimulation in the treatment of hypertension
    John D Filippone
    Cardiology Division, Department of Medicine, University of Rochester Medical Center, Rochester, New York 14642 8679, USA
    Curr Opin Nephrol Hypertens 16:403-8. 2007
    ..Electrical stimulation of the carotid sinus is a novel treatment for hypertension, and has been shown to reduce blood pressure by activating the baroreflex and reducing sympathetic tone...
  13. doi request reprint Comparison of acute electrocardiographic presentation in patients with diastolic vs systolic heart failure
    Karolina M Zareba
    University of Rochester Medical Center, Rochester, NY, USA
    Congest Heart Fail 15:165-9. 2009
    ..In the SHF group, CEs were associated with AF. Admission ECG differs between acute DHF and SHF patients. CE rates are similar in both groups; AF is the only ECG parameter predictive of CEs...
  14. doi request reprint Perioperative hypertension: defining at-risk patients and their management
    Susan F Lien
    Division of Cardiology, University of Rochester Medical Center, Rochester, NY, USA
    Curr Hypertens Rep 14:432-41. 2012
    ..This review also examines the parenteral antihypertensive medications most commonly administered in the perioperative setting...
  15. ncbi request reprint Baroreflex device therapy in the treatment of hypertension
    Sarada C Uppuluri
    Department of Internal Medicine, Cardiology Division, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY 14642, USA
    Curr Hypertens Rep 11:69-75. 2009
    ..These promising results indicate that this modality has the potential to become a useful tool in future treatment of hypertension...
  16. ncbi request reprint Electrical stimulation of the carotid sinus for the treatment of resistant hypertension
    J D Filippone
    Program in Heart Failure and Transplantation, Universityof Rochester, Cardiology Division, 601 Elmwood Avenue, Box 679T, Rochester, New York 14642 8679, USA
    Curr Hypertens Rep 8:420-4. 2006
    ..The carotid stimulator may be a safe and effective therapeutic option for patients with resistant hypertension...
  17. doi request reprint Interventional approaches for resistant hypertension
    Andrew C Davidson
    Department of Medicine, Cardiology Division, University of Rochester Medical Center, Rochester, New York 14642 8679, USA
    Curr Opin Nephrol Hypertens 21:475-80. 2012
    ..An interventional approach to treating patients with resistant hypertension may provide a supplementary aid to those with difficult-to-control blood pressure on medications alone...
  18. doi request reprint Nondrug interventions for treatment of hypertension
    Kevin J Woolf
    Division of Cardiology, University of Rochester Medical Center, Rochester, NY, USA
    J Clin Hypertens (Greenwich) 13:829-35. 2011
    ..Lifestyle modification remains a necessary part of treatment for all patients with hypertension. This article will review the evidence behind some available nondrug interventions for the treatment of hypertension...
  19. ncbi request reprint Hypertension in the very elderly: Brief review of management
    Magdalena A Zeglin
    Department of Internal Medicine, Division of Cardiology, University of Rochester Medical Center, Rochester, NY, USA
    Cardiol J 16:379-85. 2009
    ..Data from clinical trials including HYVET favor thiazide diuretics, angiotensin converting enzyme inhibitors and calcium channel blockers for either mono-therapy or combination therapy for hypertension in the elderly...
  20. ncbi request reprint Direct renin inhibition: an analysis of possible benefits
    Brian K Dockery
    University of Rochester Medical Center, Department of Internal Medicine Cardiology Division, 601 Elmwood Avenue, Box 679 7, Rochester, NY 14642, USA
    Curr Hypertens Rep 10:313-8. 2008
    ..Clinical studies are ongoing and future studies are planned to prove its effectiveness in several chronic diseases known to be related to RAAS activation...
  21. ncbi request reprint Predictive value of admission electrocardiography in patients with heart failure
    Karolina M Zareba
    University of Rochester Medical Center, Rochester, NY, USA
    Congest Heart Fail 14:173-9. 2008
    ..In conclusion, apart from AF, the presence of short QTpc <or=360 ms is independently associated with increased risk of rehospitalization or death in HF patients...
  22. doi request reprint Effect of nicotine replacement therapy on cardiovascular outcomes after acute coronary syndromes
    Kevin J Woolf
    University of Rochester Medical Center, Rochester, New York, USA
    Am J Cardiol 110:968-70. 2012
    ..01, 95% confidence interval 0.66 to 1.53, p = 0.97). In conclusion, NRT use was not associated with an increased risk of adverse cardiovascular events in the first year after ACS...
  23. ncbi request reprint The future of endothelin-receptor antagonism as treatment for systemic hypertension
    Gabriel Vorobiof
    Program in Heart Failure and Transplantation, University of Rochester, Cardiology Division, 601 Elmwood Avenue, Box 679T, Rochester, NY 14642 8679, USA
    Curr Hypertens Rep 8:35-44. 2006
    ..This review serves to summarize the current role of ET and ET receptor antagonists in both the pathophysiology and the treatment of hypertension...
  24. ncbi request reprint Allergic respiratory disease as a potential co-morbidity for hypertension
    Tania Aung
    Department of Internal Medicine, University of Rochester Medical Center, Rochester, New York, USA
    Cardiol J 17:443-7. 2010
    ..Although associations between allergic diseases and hypertension have been reported, more studies need to be performed to elucidate the mechanisms behind such associations...
  25. ncbi request reprint The role of continuous positive airway pressure in the treatment of hypertension in patients with obstructive sleep apnea-hypoapnea syndrome: a review of randomized trials
    Mohan Rao
    Department of Internal Medicine, Cardiology Division, University of Rochester Medical Center, Rochester, NY, USA
    Rev Recent Clin Trials 5:35-42. 2010
    ..However, whether it is effective in treating hypertension in this population remains unclear. This review evaluates the recent literature that investigates the effects of nCPAP ventilation on hypertension in patients with OSA...
  26. ncbi request reprint Comparison of prognostic significance of amino-terminal pro-brain natriuretic Peptide versus blood urea nitrogen for predicting events in patients hospitalized for heart failure
    Heather J Shenkman
    Cardiology Division, Department of Medicine, University of Rochester Medical Center, Rochester, New York, USA
    Am J Cardiol 99:1143-5. 2007
    ..BUN outperforms NT-pro-BNP in predicting mortality in patients with advanced HF. If admitting physicians are confident that the diagnosis of HF is correct, then admission NT-pro-BNP adds little to clinical management...
  27. doi request reprint Hypertension in pregnancy and women of childbearing age
    Scott R Yoder
    Department of Internal Medicine, Cardiology Division, University of Rochester Medical Center, Rochester, New York 4642 8679, USA
    Am J Med 122:890-5. 2009
    ....
  28. ncbi request reprint Metoprolol succinate therapy associated with erythema multiforme
    Jaekyoung A Hong
    Department of Internal Medicine, Division of Cardiology, University of Rochester Medical Center, Rochester, NY 14642, USA
    Cardiol J 16:82-3. 2009
    ..While erythema multiforme has been reported with carvedilol, this is the first observation of metoprolol succinate causing this and physicians should be aware of this potential, yet rare, side-effect...
  29. ncbi request reprint Diffuse large B cell lymphoma presenting as a cardiac mass and odynophagia
    Makiko Ban-Hoefen
    Department of Internal Medicine, Division of Cardiology, University of Rochester Medical Center, Rochester, NY, USA
    Cardiol J 15:471-4. 2008
    ..This case illustrates lymphoma presenting with dyspnea, odynophagia and a left atrial mass. To our knowledge, there are no reported cases of diffuse large B cell lymphoma presenting as odynophagia and a cardiac mass...
  30. ncbi request reprint Characteristics and management of patients presenting to the emergency department with hypertensive urgency
    Seth R Bender
    University of Rochester Medical Center, Cardiology Division, Rochester, NY 14642, USA
    J Clin Hypertens (Greenwich) 8:12-8. 2006
    ..Emergency department visits for hypertensive urgency are related mostly to noncompliance. Labetalol was the most frequently used therapy. Management in the primary care office could result in substantial cost savings...
  31. ncbi request reprint Comparison of patients with acute coronary syndrome with and without systemic hypertension
    Silja K Majahalme
    Tampere University Hospital, Tampere, Finland
    Am J Cardiol 92:258-63. 2003
    ....
  32. ncbi request reprint Vascular disease in an expanding world: seeking answers inside and outside of the box
    James A Sloand
    J Clin Hypertens (Greenwich) 9:246-8. 2007
  33. ncbi request reprint Leukoaraiosis: the brain under pressure: target for treatment?
    Michael D Hill
    Neurology 64:1832-3. 2005
  34. ncbi request reprint VALUE in hypertension treatment
    Bradford C Berk
    Curr Hypertens Rep 6:411-3. 2004
  35. ncbi request reprint Attenuation of haemodynamic, metabolic and energy expenditure responses to isoproterenol in patients with hypertension
    Mariaconsuelo Valentini
    Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, Michigan 48109, USA
    J Hypertens 22:1999-2006. 2004
    ..beta-adrenoceptor down-regulation has been described in hypertension. We tested the hypothesis that chronic sympathetic overactivity impairs beta-adrenergic-mediated thermogenesis and thereby favours gain of weight in hypertension...